Brier, WA, United States of America

Daniel R Storm


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Seattle, WA (US) (2002)
  • Brier, WA (US) (2005 - 2007)

Company Filing History:


Years Active: 2002-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: An Overview of Inventor Daniel R. Storm

Introduction

Daniel R. Storm, an accomplished inventor based in Brier, Washington, has made significant contributions to the field of biochemistry and molecular biology. With a portfolio of three patents, Storm has pioneered inventions that focus on adenylyl cyclase, a key enzyme that plays an essential role in cellular signaling.

Latest Patents

Storm's latest patents include a groundbreaking method for identifying candidate compounds that bind to human type IX adenylyl cyclase polypeptides. This invention involves novel human adenylyl cyclase nucleic acid and amino acid sequences, vectors, host cells, and recombinant methods for producing and utilizing these innovative molecules. Another notable patent from Storm is the cloning and characterization of a human adenylyl cyclase, which describes a DNA sequence encoding the enzyme along with its amino acid sequence.

Career Highlights

Throughout his career, Daniel R. Storm has worked with prestigious organizations, including Millennium Pharmaceuticals Limited. His research and developments have greatly contributed to advancements in therapeutic solutions targeting cellular signaling pathways.

Collaborations

In his professional journey, Storm has collaborated with notable colleagues, including Beth Hacker and James E. Tomlinson. Their collective expertise has likely enhanced the innovative projects that Storm has undertaken.

Conclusion

Daniel R. Storm's innovative work in the field of adenylyl cyclase research and development has solidified his reputation as a leading inventor. With ongoing advancements in his patented methodologies, Storm continues to contribute to the scientific community and the evolution of biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…